Adage Capital Partners’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.06M Buy
644,134
+300,000
+87% +$495K ﹤0.01% 790
2025
Q1
$544K Buy
344,134
+190,000
+123% +$300K ﹤0.01% 810
2024
Q4
$516K Buy
+154,134
New +$516K ﹤0.01% 838